World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
86
Citations
23213
World Ranking
1283
National Ranking
31

Luc Perrin publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Luc Perrin sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 263 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Luc Perrin D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Luc Perrin sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 86 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Luc Perrin is affiliated with the University of Geneva in Switzerland and specializes in the field of Chemistry. Their research spans multiple subfields, primarily focusing on Organic Chemistry, Materials Chemistry, Inorganic Chemistry, Molecular Biology, and Electrical and Electronic Engineering.

The main topics of their work include:

  • Organometallic Complex Synthesis and Catalysis
  • Catalytic Cross-Coupling Reactions
  • Advanced Polymer Synthesis and Characterization
  • Catalytic C-H Functionalization Methods
  • Coordination Chemistry and Organometallics
  • Chemical Synthesis and Analysis
  • Crystallization and Solubility Studies

Their recent publications demonstrate a focus on catalysis and polymer chemistry. Notable papers include:

  • "We Already Know Everything about Oxidative Addition to Pd(0): Do We?" (2023), published in ACS Catalysis
  • "Iodine-Transfer Polymerization (ITP) of Ethylene and Copolymerization with Vinyl Acetate" (2020), published in Angewandte Chemie International Edition
  • "Shedding Light on the Hidden Roles of Lithium in the Nickel-Catalyzed Cross-Coupling of Aryl Ethers" (2023), published in Journal of the American Chemical Society
  • "Electrochemically Driven Nickel-Catalyzed Halogenation of Unsaturated Halide and Triflate Derivatives" (2023), published in Angewandte Chemie International Edition
  • "Design of selective divalent chain transfer agents for coordinative chain transfer polymerization of ethylene and its copolymerization with butadiene" (2022), published in Polymer Chemistry

Frequent co-authors in their collaborations include Pierre-Adrien Payard, Jordan Rio, Ludmilla Verrieux, Franck D'Agosto, and Haosheng Liang.

Their studies have appeared repeatedly in several scientific venues, with multiple publications in The Cambridge Structural Database, ACS Catalysis, Zenodo (CERN European Organization for Nuclear Research), Angewandte Chemie International Edition, and Angewandte Chemie. This distribution indicates an engagement with both chemical databases and prominent journals in catalysis and applied chemistry.

Best Publications

  • Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

    Bastien Mangeat;Priscilla Turelli;Gersende Caron;Marc Friedli

  • Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.

    Gilbert Greub;Bruno Ledergerber;M. Battegay;P. Grob

  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

    Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  • Transmission of antiretroviral-drug-resistant HIV-1 variants

    S Yerly;L Kaiser;E Race;J P Bru

  • CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years: The Swiss HIV Cohort Study

    Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil

  • Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

    Gilbert R. Kaufmann;Hansjakob Furrer;Bruno Ledergerber;Luc Perrin

  • Hepatitis C virus in patients with cryoglobulinemia type II.

    Manuel Pascual;Luc Perrin;Emilio Giostra;Jürg A. Schifferli

  • Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen

    Nicolas Sachsenberg;Alan S. Perelson;Sabine Yerly;Gérard A. Schockmel

  • Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.

    R H Zubler;U Nydegger;L H Perrin;k Fehr

  • The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia

    Giuseppe Pantaleo;James F. Demarest;Timothy Schacker;Mauro Vaccarezza

  • Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

    L H Perrin;P H Lambert;P A Miescher

  • A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection

    Sabine Kinloch De Loës;Bernard J. Hirschel;Bruno Hoen;David A. Cooper

  • HIV Viral Load Monitoring in Resource-Limited Regions: Optional or Necessary?

    Alexandra Calmy;Alexandra Calmy;Nathan Ford;Bernard Hirschel;Steven J. Reynolds

  • A Patient with HIV-1 Superinfection

    Stephanie Jost;Marie-Charlotte Bernard;Laurent Kaiser;Sabine Yerly

  • Acute HIV infection: impact on the spread of HIV and transmission of drug resistance.

    S Yerly;S Vora;P Rizzardi;J P Chave

  • CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1 : results of the staccato randomised trial

    Jintanat Ananworanich;Angèle Gayet-Ageron;Michelle Le Braz;Wisit Prasithsirikul

  • Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

    Annette Oxenius;David A. Price;Huldrych F. Günthard;Sara J. Dawson

  • HIV treatment failure : Testing for HIV resistance in clinical practice

    Luc Perrin;Amalio Telenti

  • Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.

    Patrizio Lorenzi;Milos Opravil;Bernard Hirschel;Jean-Philippe Chave

  • Impact of Treatment with Human Immunodeficiency Virus (HIV) Protease Inhibitors on Hepatitis C Viremia in Patients Coinfected with HIV

    Olivier Thierry Rutschmann;Francesco Negro;Bernard Hirschel;Antoine Hadengue

  • CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years

    Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil

Frequent Co-Authors

Sabine Yerly
Sabine Yerly University of Geneva
Bernard Hirschel
Bernard Hirschel University of Geneva
Laurent Kaiser
Laurent Kaiser Hôpitaux Universitaires de Genève
Amalio Telenti
Amalio Telenti VIR Biotechnology (United States)
Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Hansjakob Furrer
Hansjakob Furrer University of Bern
Pietro Vernazza
Pietro Vernazza University of St. Gallen
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
David A. Cooper
David A. Cooper University of New South Wales
Manuel Battegay
Manuel Battegay University Hospital of Basel

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open up diverse career opportunities. Many professionals start with foundational nursing programs, such as easiest accelerated nursing programs, which provide a fast track into nursing careers. These programs are ideal for individuals seeking a quicker transition into the field.

For those without prior nursing education, online BSN programs for non nurses offer flexible options to earn a Bachelor of Science in Nursing. This approach facilitates entry into clinical and research roles allied with immunology.

Additionally, pursuing best easiest LPN programs to get into can provide foundational experience in patient care, which is critical for understanding immune system-related conditions in clinical settings.

Advanced practice roles, such as those obtained through accelerated nurse practitioner programs, enable specialization and leadership within immunology-related healthcare environments. These programs enhance both clinical expertise and research potential, making them valuable for career growth.

Best Scientists Citing Luc Perrin

Trending Scientists

Recently Published Articles